Carmat SA (ALCAR.PA)
EUR 1.0
(-1.09%)
EUR 1.0
(-1.09%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 49.63 Million EUR | 7199.41% |
| 2022 | 680 Thousand EUR | -95.59% |
| 2021 | 15.43 Million EUR | 421.99% |
| 2020 | 2.95 Million EUR | 109.77% |
| 2019 | -30.26 Million EUR | -147.16% |
| 2018 | -12.24 Million EUR | 74.31% |
| 2017 | -47.66 Million EUR | -163.25% |
| 2016 | -18.1 Million EUR | -285.63% |
| 2015 | 9.75 Million EUR | 174.97% |
| 2014 | 3.54 Million EUR | 122.08% |
| 2013 | -16.06 Million EUR | -50.47% |
| 2012 | -10.67 Million EUR | 44.78% |
| 2011 | -19.32 Million EUR | -391.2% |
| 2010 | -3.93 Million EUR | -1473.92% |
| 2009 | 286.42 Thousand EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 47.08 Million EUR | 0.0% |
| 2023 Q4 | 49.63 Million EUR | 0.0% |
| 2023 Q2 | 18.94 Million EUR | 0.0% |
| 2023 FY | 49.63 Million EUR | 7199.41% |
| 2022 Q2 | 6.62 Million EUR | 0.0% |
| 2022 FY | 680 Thousand EUR | -95.59% |
| 2022 Q4 | 680 Thousand EUR | 0.0% |
| 2021 FY | 15.43 Million EUR | 421.99% |
| 2021 Q2 | -13.42 Million EUR | 0.0% |
| 2021 Q4 | 15.43 Million EUR | 0.0% |
| 2020 Q4 | 2.95 Million EUR | 0.0% |
| 2020 Q2 | -9.49 Million EUR | 0.0% |
| 2020 FY | 2.95 Million EUR | 109.77% |
| 2019 Q2 | 14.23 Million EUR | 0.0% |
| 2019 Q4 | -30.26 Million EUR | 0.0% |
| 2019 FY | -30.26 Million EUR | -147.16% |
| 2018 FY | -12.24 Million EUR | 74.31% |
| 2018 Q2 | -39.81 Million EUR | 0.0% |
| 2018 Q4 | -12.24 Million EUR | 0.0% |
| 2017 FY | -47.66 Million EUR | -163.25% |
| 2017 Q4 | -57 Million EUR | 0.0% |
| 2017 Q2 | -16.01 Million EUR | 0.0% |
| 2016 Q2 | -40.32 Million EUR | 0.0% |
| 2016 Q4 | -27.95 Million EUR | 0.0% |
| 2016 FY | -18.1 Million EUR | -285.63% |
| 2015 Q2 | -8.22 Million EUR | 0.0% |
| 2015 FY | 9.75 Million EUR | 174.97% |
| 2015 Q4 | -788.33 Thousand EUR | 0.0% |
| 2014 Q2 | -6.64 Million EUR | 0.0% |
| 2014 Q4 | -7.87 Million EUR | 0.0% |
| 2014 FY | 3.54 Million EUR | 122.08% |
| 2013 Q4 | -16.06 Million EUR | 0.0% |
| 2013 FY | -16.06 Million EUR | -50.47% |
| 2013 Q2 | -7.86 Million EUR | 0.0% |
| 2012 FY | -10.67 Million EUR | 44.78% |
| 2012 Q2 | -6.11 Million EUR | 0.0% |
| 2012 Q4 | -10.67 Million EUR | 0.0% |
| 2011 FY | -19.32 Million EUR | -391.2% |
| 2011 Q2 | -3.93 Million EUR | 0.0% |
| 2011 Q4 | -19.32 Million EUR | 0.0% |
| 2010 Q2 | 1.58 Million EUR | 0.0% |
| 2010 Q4 | -3.93 Million EUR | 0.0% |
| 2010 FY | -3.93 Million EUR | -1473.92% |
| 2009 FY | 286.42 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | -220.729% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | 5799.869% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | -330.569% |
| Euromedis Groupe | -8.82 Million EUR | 662.374% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 3.306% |
| Ikonisys S.A. | 3.19 Million EUR | -1452.047% |
| Implanet S.A. | 5.9 Million EUR | -740.861% |
| Median Technologies SA | 3.5 Million EUR | -1315.744% |
| SpineGuard SA | 215.79 Thousand EUR | -22901.247% |
| Theraclion SA | -5.86 Million EUR | 946.376% |
| Euroapi S.A. | 191 Million EUR | 74.013% |
| Guerbet SA | 332.59 Million EUR | 85.076% |
| Ion Beam Applications SA | -67.72 Million EUR | 173.293% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 99.147% |
| Sequana Medical NV | 14.2 Million EUR | -249.48% |